Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gut mycobiota composition in children after aHSCT

ABSTRACT: Intestinal mycobiota composition of children with thalassemia undergoing allogeneic hematopoietic stem cell transplantation

PROVIDER: PRJEB46003 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR6153520_1.fastq.gz	Fastqsanger.gz
	ERR6153520_2.fastq.gz	Fastqsanger.gz
	ERR6153530_1.fastq.gz	Fastqsanger.gz
	ERR6153530_2.fastq.gz	Fastqsanger.gz
	ERR6153540_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 124

Similar Datasets

Project description:Intestinal Mycobiota and Microbiota of patients undergoing allogeneic hematopoietic cell transplantation.

| PRJNA746305 | ENA

Transcription profiling of mononuclear cells from patients undergoing allogenic hematopoitic cell transplantation to identify signatures of acute graft-versus-host disease

Project description:To assess if gene expression signatures could predict acute graft-versus-host disease, we examined the global gene expression profiles of peripheral blood mononuclear cells at day +14 post-transplantation from 94 patients undergoing allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.

2010-06-09 | E-MEXP-1824 | biostudies-arrayexpress

Immune Mediated Disorders after Allo-HCG

Project description:Allogeneic hematopoietic cell transplantation (HCT) is the only known curative option for many hematologic disorders. After transplantation, many patients develop immune mediated disorders that may be life-threatening. Post-HCT immune mediated disorders are rare relative to other diseases but the prototype of graft versus host disease (GVHD) develops in 30-70% of patients. The morbidity and mortality associated with these HCT-associated immune mediated disorders are major barriers to successful use of transplantation to cure rare hematologic malignancies such as leukemia, lymphoma, multiple myeloma, myelodysplastic/myeloproliferative syndromes amongst other diseases. The purpose of this study is to characterize and more completely define the onset and course of immune mediated disorders after allogeneic HCT, focusing on participants who develop cutaneous sclerosis, bronchiolitis obliterans syndrome (BOS), late acute graft-vs.-host disease (GVHD), and chronic GVHD. <ul> <li>Of the participants undergoing allogeneic hematopoietic cell transplantation (HCT), can we, the researchers better identify who will develop immune-mediated disorders, what types of disorders participants will have, and whether these disorders will be severe or respond to currently available therapies?</li> </ul> This is a longitudinal study of 1118 individuals (1081 adults and 100 children). Those participating in this study will be evaluated over a 3 year period at 9 study sites. Participants will be enrolled pre-transplant, or up to day 121 post transplantation. This wide enrollment window will allow sites to use recruitment methods that are most efficient at their institutions. At least 2 years of follow-up will ensure an adequate sample size, and sufficient time for observation of the full spectrum of immune mediated disorders. The data of 1023 individuals have been submitted to dbGaP.

| phs001331 | dbGaP

Mycobiota composition of Nebbiolo grape

Project description:Mycobiota composition of Nebbiolo grape

| PRJNA575160 | ENA

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

Project description:The aim of this study is to assess the Fecal Microbiota Transplantation (FMT) efficacy in the prevention of allogeneic hematopoietic stem cell transplantation (allo-HSCT) complications and particularly Graft versus Host Disease (GvHD). The hypothesis of this study is that allogeneic FMT may improve outcomes of these patients.

| 2381286 | ecrin-mdr-crc

FK506 and Lactobacillus acidophilus Ameliorate Acute Graft-Versus-Host Disease by Modulating the T Helper 17/Regulatory T-Cell Balance

Project description:Graft-versus-host disease (GvHD) is critical complication after allogeneic hematopoietic stem cell transplantation (HSCT). The immunosuppressants given to patients undergoing allogeneic HSCT disturb the microbiome and the host immune system, potentially leading to dysbiosis and inflammation. The intestinal microbiome is a target for the development of novel therapies for GvHD. We determined the effect of the combination of tacrolimus (FK506) and Lactobacillus acidophilus on GvHD.

2021-05-11 | GSE174214 | GEO

Rhizosphere Mycobiota composition of Cucurbita pepo

Project description:Rhizosphere Mycobiota composition of Cucurbita pepo

| PRJNA580394 | ENA

Microbiota and Mycobiota composition of meat

Project description:Microbiota and Mycobiota composition of meat Raw sequence reads

| PRJNA777553 | ENA

Metagenomic Next-Generation Sequencing Achieves Timely and Precise Pathogen Detection of Severe Pneumonia in Children with Hematologic Malignancy or undergoing allogeneic hematopoietic stem cell transplantation

Project description:Metagenomic Next-Generation Sequencing Achieves Timely and Precise Pathogen Detection of Severe Pneumonia in Children with Hematologic Malignancy or undergoing allogeneic hematopoietic stem cell transplantation

| PRJEB43570 | ENA

ASD gut mycobiota

Project description:ASD gut mycobiota

| PRJEB15420 | ENA